BCG vaccination in patients with severe combined immunodeficiency: Complications, risks, and vaccination policies
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F14%3A00077681" target="_blank" >RIV/00216224:14110/14:00077681 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/14:10292786 RIV/00159816:_____/14:00061366 RIV/00064203:_____/14:10292786
Result on the web
<a href="http://dx.doi.org/10.1016/j.jaci.2014.02.028" target="_blank" >http://dx.doi.org/10.1016/j.jaci.2014.02.028</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.jaci.2014.02.028" target="_blank" >10.1016/j.jaci.2014.02.028</a>
Alternative languages
Result language
angličtina
Original language name
BCG vaccination in patients with severe combined immunodeficiency: Complications, risks, and vaccination policies
Original language description
Background: Severe combined immunodeficiency (SCID) is a syndrome characterized by profound T-cell deficiency. BCG vaccine is contraindicated in patients with SCID. Because most countries encourage BCG vaccination at birth, a high percentage of patientswith SCID are vaccinated before their immune defect is detected. Objectives: We sought to describe the complications and risks associated with BCG vaccination in patients with SCID. Methods: An extensive standardized questionnaire evaluating complications, therapeutics, and outcomes regarding BCG vaccination in patients given a diagnosis of SCID was widely distributed. Summary statistics and association analysis was performed. Results: Data on 349 BCG-vaccinated patients with SCID from 28 centers in 17countries were analyzed. Fifty-one percent of the patients had BCG-associated complications, 34% disseminated and 17% localized (a 33,000- and 400-fold increase, respectively, over the general population).
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EC - Immunology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of allergy and clinical immunology
ISSN
0091-6749
e-ISSN
—
Volume of the periodical
133
Issue of the periodical within the volume
4
Country of publishing house
US - UNITED STATES
Number of pages
8
Pages from-to
1134-1141
UT code for WoS article
000333531700025
EID of the result in the Scopus database
—